Is BYSI or CAPR more undervalued in 2026?

CirclFi compares BeyondSpring, Inc. (BYSI) and Capricor Therapeutics, Inc. (CAPR) using 13 institutional-grade valuation models. BYSI has a Quality of Company score of 3.5/10 while CAPR scores 6.9/10.

Which is a better buy — BYSI or CAPR?

Compare intrinsic values from 13 independent models against current market prices. CirclFi also calculates Value Trap scores. This is not financial advice — conduct your own analysis.

How do BYSI and CAPR valuations compare?

BYSI at $1.68 and CAPR at $29.96 are compared across Bayesian DCF, EPV, EROIC Spread, First Chicago, Markov DDM, and 8 additional models.

BYSI vs CAPR Valuation Comparison 2026 — Intrinsic Value Analysis

BYSI

Pharmaceutical Preparations

BeyondSpring, Inc.

Quality

3.5

out of 10

Value Trap

SAFE

Price

$1.68

Last close

Models

10/13

Active

CAPR

Pharmaceutical Preparations

Capricor Therapeutics, Inc.

Quality

6.9

out of 10

Value Trap

SAFE

Price

$29.96

Last close

Models

12/13

Active

Model-by-Model Comparison

Model	Type	BYSI Fair Value	BYSI Upside	CAPR Fair Value	CAPR Upside
Bayesian DCF	Intrinsic	$3.63	+152.2%	$6.55	-78.1%
Earnings Power Value	Intrinsic	$0.75	-49.6%	$15.35	-56.5%
EROIC Spread	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
First Chicago	Scenario	$•••.••	••.•%	$•••.••	••.•%
Markov DDM	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
ML-RIV	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
Dynamic NAV	Asset-Based	$•••.••	••.•%	$•••.••	••.•%
PWERM	Option-Based	$•••.••	••.•%	$•••.••	••.•%
Regime Cross-Sectional	Relative	$•••.••	••.•%	$•••.••	••.•%
Sentiment SOTP	Hybrid	$•••.••	••.•%	$•••.••	••.•%
CUCE Ensemble	Ensemble	$•••.••	••.•%	$•••.••	••.•%
FTNN Topology	Relative	$•••.••	••.•%	$•••.••	••.•%
RCMH-DCF	Intrinsic	$•••.••	••.•%	$•••.••	••.•%

🔒

Unlock Full 13-Model Comparison

Access all valuation models for BYSI vs CAPR — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

BYSI vs CAPR — Which Stock Is More Undervalued?

CAPR scores higher with a 6.9/10 quality rating vs BYSI's 3.5/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing BeyondSpring, Inc. (BYSI) and Capricor Therapeutics, Inc. (CAPR) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

BYSI currently trades at $1.68 with a QOC of 3.5/10, while CAPR trades at $29.96 with a QOC of 6.9/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).